Diagnostic Yield of Acid Fast Bacilli in Bronchoalveolar Lavage of Sputum-Negative Pulmonary Tuberculosis Patients
DOI:
https://doi.org/10.54112/bcsrj.v6i4.1633Keywords:
Bronchoalveolar lavage, Pulmonary tuberculosis, Sputum NegativeAbstract
Pulmonary tuberculosis (PTB) remains a significant public health concern, especially in high-burden countries like Pakistan. Diagnosis becomes particularly challenging in sputum-negative patients, leading to delayed treatment and increased transmission. Bronchoalveolar lavage (BAL) has emerged as a potential diagnostic tool in such cases. Objective: To determine the diagnostic yield of acid-fast bacilli (AFB) in bronchoalveolar lavage of sputum-negative pulmonary tuberculosis patients. Methods: This cross-sectional study was conducted in the Department of Pulmonology, Gulab Devi Hospital, Lahore, over six months from June to December 2024. One hundred fifty sputum-negative PTB patients undergoing BAL were enrolled through consecutive sampling. BAL samples were collected and sent to the pathology laboratory for AFB testing via Ziehl-Neelsen staining. The primary outcome was the proportion of positive AFB results among the study population. Data were analyzed using SPSS version 25. Chi-square test was applied to assess associations between diagnostic yield and demographic or clinical variables; a p-value < 0.05 was considered statistically significant. Results: Among 150 patients, 71.3% (n = 107) were male; the mean age was 42.81 ± 11.23 years. Most participants (72.0%) were aged ≤45 years. A majority (68.0%) resided in rural areas, and 62.7% belonged to a low socioeconomic status. Comorbidities included diabetes (32.7%), hypertension (40.7%), and obesity (9.3%). The mean disease duration was 2.36 ± 1.09 months, with 80.7% having symptoms for ≤3 Months. Family history of TB and smoking history were noted in 26.0% and 22.0%, respectively. Most patients were unskilled workers (47.3%) or housewives (24.0%). The diagnostic yield of BAL for AFB was 83.3% (n = 125). Diagnostic yield was significantly associated with gender (p < 0.05), residential status (p < 0.05), disease duration (p < 0.05), and occupation (p < 0.05). Conclusion: Bronchoalveolar lavage demonstrates a high diagnostic yield for AFB in sputum-negative PTB patients and should be incorporated as a standard diagnostic modality in suspected cases. Early and accurate diagnosis through BAL can facilitate timely management, reduce disease transmission, and improve patient outcomes, particularly in resource-limited settings.
Downloads
References
Rakha MA, Ali A, Hassan W, Al-Anbay E. GeneXpert analysis of bronchoalveolar lavage (BAL) samples: promising diagnostic modality in patients with smear-negative pulmonary tuberculosis. The Egyptian Journal of Bronchology. 2022;16(1):68.
Koraa EE-DA, Abdel-Fattah EB, El-Touny RM. Diagnostic yield of bronchoalveolar lavage GeneXpert in smear-negative and sputum-scarce pulmonary tuberculosis. The Egyptian Journal of Chest Diseases and Tuberculosis. 2021;70(4):469-73.
Dhakal SS, Neupane A, Chaudhary S, Mishra N, Karki DB. Utility of Bronchoalveolar Lavage in the Diagnosis of Sputum Negative Pulmonary Tuberculosis. Journal of Universal College of Medical Sciences. 2020;8(1):19-22.
Uddin MKM, Ather MF, Akter S, Nasrin R, Rahman T, Kabir SN, et al. Diagnostic Yield of Xpert MTB/RIF Assay Using Bronchoalveolar Lavage Fluid in Detecting Mycobacterium tuberculosis among the Sputum-Scarce Suspected Pulmonary TB Patients. Diagnostics. 2022;12(7):1676.
Nikbakhsh N, Bayani M, Siadati S. The Value of Bronchoalveolar Lavage in the Diagnosis of Sputum Smear-NegativePulmonary Tuberculosis. Iranian journal of pathology. 2015;10(1):35-40.
Brito GMX, Mafort TT, Ribeiro-Alves M, Reis LVTD, Leung J, Leão RS, Rufino R, Rodrigues LS. Diagnostic performance of the Xpert MTB/RIF assay in BAL fluid samples from patients under clinical suspicion of pulmonary tuberculosis: a tertiary care experience in a high-tuberculosis-burden area. J Bras Pneumol. 2021 May 17;47(2):e20200581. doi: 10.36416/1806-3756/e20200581. PMID: 34008762; PMCID: PMC8332835.
Iúdice TNDS, da Conceição ML, de Brito AC, de Souza NM, Mesquita CR, Guimarães RJPSE, Furlaneto IP, Saboia AS, Lourenço MCDS, Lima KVB, Conceição EC. The Role of GeneXpert® for Tuberculosis Diagnostics in Brazil: An Examination from a Historical and Epidemiological Perspective. Trop Med Infect Dis. 2023 Oct 26;8(11):483. doi: 10.3390/tropicalmed8110483. PMID: 37999602; PMCID: PMC10674801.
Villalva-Serra K, Barreto-Duarte B, Miguez-Pinto JP, Queiroz ATL, Rodrigues MM, Rebeiro PF, Amorim G, Cordeiro-Santos M, Sterling TR, Araújo-Pereira M, Andrade BB. Impact of Xpert MTB/RIF implementation in tuberculosis case detection and control in Brazil: a nationwide intervention time-series analysis (2011-2022). Lancet Reg Health Am. 2024 Jun 5;36:100804. doi: 10.1016/j.lana.2024.100804. PMID: 38912329; PMCID: PMC11192787.
Conceição EC, Loubser J, Guimarães AEDS, Sharma A, Rutaihwa LK, Dippenaar A, Salvato RS, de Paula Souza E Guimarães RJ, da Silva Lourenço MC, Barros WA, Cardoso NC, Warren RM, Gagneux S, Grinsztejn BGJ, Suffys PN, Lima KVB. A Genome-Focused Investigation Reveals the Emergence of a Mycobacterium tuberculosis Strain Related to Multidrug-Resistant Tuberculosis in the Amazon Region of Brazil. Microorganisms. 2024 Sep 2;12(9):1817. doi: 10.3390/microorganisms12091817. PMID: 39338491; PMCID: PMC11434004.
Shibabaw A, Gelaw B, Ghanem M, Legall N, Schooley AM, Soehnlen MK, Salvador LCM, Gebreyes W, Wang SH, Tessema B. Molecular epidemiology and transmission dynamics of multi-drug resistant tuberculosis strains using whole genome sequencing in the Amhara region, Ethiopia. BMC Genomics. 2023 Jul 17;24(1):400. doi: 10.1186/s12864-023-09502-2. PMID: 37460951; PMCID: PMC10351181.
Zhu N, Zhou D, Xiong W, Zhang X, Li S. Performance of mNGS in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients. Front Cell Infect Microbiol. 2023 Oct 31;13:1271853. doi: 10.3389/fcimb.2023.1271853. PMID: 38029249; PMCID: PMC10644336.
Li C, Sun L, Liu Y, Zhou H, Chen J, She M, Wang Y. Diagnostic value of bronchoalveolar lavage fluid galactomannan assay for invasive pulmonary aspergillosis in adults: A meta-analysis. J Clin Pharm Ther. 2022 Dec;47(12):1913-1922. doi: 10.1111/jcpt.13792. Epub 2022 Nov 2. PMID: 36324286.
Imtiaz S, Batubara EM. Diagnostic value of bronchoscopy in sputum-negative pulmonary tuberculosis patients and its correlation with clinicoradiological features. Annals of thoracic medicine. 2022;17(2):124-31.
Pokharel A, Bhandari C, Sharma B, Bhandari R, Paudel Y. Diagnostic Value of Bronchoalveolar Lavage in Sputum-Smear Negative Pulmonary Tuberculosis. Journal of National Heart and Lung Society Nepal. 2023 Dec 31;2(2):77-80.
Hu X, Jiang L, Liu X, Chang H, Dong H, Yan J, Zhou X, Kong M. The diagnostic value of bronchoalveolar lavage fluid metagenomic next-generation sequencing in critically ill patients with respiratory tract infections. Microbiology Spectrum. 2024 Aug 6;12(8):e00458-24.
Alam M, Shahzad MI, Pervaiz S, Jamil M, Afzal MW, Mushtaq A. Comparison of Induced Sputum with Bronchoalveolar Lavage Samples for Pulmonary Tuberculosis diagnosis in sputum scarce Patients. Pak J Chest Med 2020; 26 (3):140-144.
Koraa EA, Eman BA, Rana EM.Diagnostic yield of bronchoalveolar lavage GeneXpert in smear-negative and sputum-scarce pulmonary tuberculosis. Egyptian J Chest Dis Tuber. 2021;70(4):469-73.DOI: 10.4103/ecdt.ecdt_29_21.
Ahmad M, Ibrahim WH, Sarafandi SA, Shahzada KS, Ahmed S, Haq IU, Raza T, et al. Diagnostic value of bronchoalveolar lavage in the subset of patients with negative sputum/smear and mycobacterial culture and a suspicion of pulmonary tuberculosis. Int J Infect Dis. 2019 May;82:96-101. doi: 10.1016/j.ijid.2019.03.021. Epub 2019 Mar 20. PMID: 30904678.
Gaude GS, Samskruti S, Hattiholi J, Patil B. Diagnostic Yield of Bronchoalveolar lavage Xpert MTB/RIF Assay (Gene Xpert® in Sputum Smear Negative Pulmonary Tuberculosis Patients–A One Year Cross Sectional Study. SAARC J Tubercul, Lung Dis HIV/AIDS. 2019 Dec 31;17(2):1-7.
Ahammed S, Sarker MS, Ali MZ. Diagnostic Value of Bronchoalveolar Lavage Examination in Sputum Negative Patients for AFB in Suspected Pulmonary Tuberculosis. KYAMC Journal. 2021 Sep 6;12(2):84-7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Tehreem Zulfiqar Janjua, Saqib Musharaf, Arooba Zulfiqar Janjua, Faisal Hassan Zahid Chaudhery, Farzeen Bakhtawar, Anum Ashraf

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.